ArticleTechnology in cancer research & treatment
Isolation of Novel Fully Human Single-Domain Antibodies Targeting GUCY2C from a Heavy-Chain-Only Transgenic Mouse Platform.
Pingxia Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.